1. Home
  2. KTCC vs CALC Comparison

KTCC vs CALC Comparison

Compare KTCC & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

N/A

Current Price

$1.32

Market Cap

23.7M

Sector

Technology

ML Signal

N/A

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

N/A

Current Price

$1.23

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KTCC
CALC
Founded
1969
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
7.6M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
KTCC
CALC
Price
$1.32
$1.23
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $38.00
AVG Volume (30 Days)
29.9K
★ 62.6K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $467,871,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.25
$0.44
52 Week High
$4.42
$72.00

Technical Indicators

Market Signals
Indicator
KTCC
CALC
Relative Strength Index (RSI) 20.16 41.27
Support Level $1.25 $1.08
Resistance Level $2.28 $1.84
Average True Range (ATR) 0.17 0.22
MACD -0.05 0.02
Stochastic Oscillator 8.59 8.81

Price Performance

Historical Comparison
KTCC
CALC

About KTCC Key Tronic Corporation

Key Tronic Corp is a contract manufacturer offering value-added design and manufacturing services from its facilities in the United States, Mexico, and Vietnam with procurement support from its facility in China. The company provides its customers full engineering services, materials management, manufacturing facilities, assembly services, in-house testing, and distribution. Its customers include original equipment manufacturers. Its capabilities are Printed Circuit Board Assembly, Injection Molding and Tooling, Metal Fabricating and Finishing, Full Product Assembly, Design and Engineering Support, and Logistics and Repair Center, and Supply Chain Management. It operates and internally manages a single operating segment, Electronics Manufacturing Services.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: